{"transactions":[{"id":12431,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-03-03T23:10:12.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":2600,"price":235.26,"value":611676.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.14 to $235.36, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4619,"source":{"system":"sec-edgar","filing":"0001951400-26-000006","document":"form4-03032026_060309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000006/form4-03032026_060309.xml","form_type":"4"}},{"id":12430,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-03-03T23:10:12.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":10291,"price":234.66,"value":2414886.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.14 to $235.12, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7219,"source":{"system":"sec-edgar","filing":"0001951400-26-000006","document":"form4-03032026_060309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000006/form4-03032026_060309.xml","form_type":"4"}},{"id":12429,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-03-03T23:10:12.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":5777,"price":233.51,"value":1348987.27,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233 to $233.99, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":17510,"source":{"system":"sec-edgar","filing":"0001951400-26-000006","document":"form4-03032026_060309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000006/form4-03032026_060309.xml","form_type":"4"}},{"id":12428,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-03-03T23:10:12.000Z","date":"2026-02-27","kind":"tax_withholding","planned":true,"acquired":false,"shares":14850,"price":232.08,"value":3446388.0,"ownership":{"direct":true},"balance_after":23287,"source":{"system":"sec-edgar","filing":"0001951400-26-000006","document":"form4-03032026_060309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000006/form4-03032026_060309.xml","form_type":"4"}},{"id":12778,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2026-02-27T22:00:05.000Z","date":"2026-02-25","kind":"exercise","planned":true,"acquired":false,"shares":7292,"price":192.86,"value":1406335.12,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 7,292 shares on February 13, 2026 and becomes exercisable in annual increments of 7,292 on February 13, 2027, and 7,291 on February 13, 2028."}],"balance_after":14583,"derivative":{"exercise_price":192.86,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":7292},"source":{"system":"sec-edgar","filing":"0001951400-26-000004","document":"form4-02272026_050202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000004/form4-02272026_050202.xml","form_type":"4"}},{"id":12777,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2026-02-27T22:00:05.000Z","date":"2026-02-25","kind":"exercise","planned":true,"acquired":false,"shares":7775,"price":175.28,"value":1362802.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable in annual increments of 7,775 on February 15, 2025 and 7,775 on February 15, 2026, and becomes exercisable as to 7,774 shares on February 15, 2027."}],"balance_after":7774,"derivative":{"exercise_price":175.28,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":7775},"source":{"system":"sec-edgar","filing":"0001951400-26-000004","document":"form4-02272026_050202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000004/form4-02272026_050202.xml","form_type":"4"}},{"id":12776,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2026-02-27T22:00:05.000Z","date":"2026-02-25","kind":"exercise","planned":true,"acquired":false,"shares":7314,"price":149.62,"value":1094320.68,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable in annual increments of 7,315 on February 16, 2024, 7,315 on February 16, 2025, and 7,314 on February 16, 2026."}],"balance_after":0,"derivative":{"exercise_price":149.62,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":7314},"source":{"system":"sec-edgar","filing":"0001951400-26-000004","document":"form4-02272026_050202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000004/form4-02272026_050202.xml","form_type":"4"}},{"id":12775,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-02-27T22:00:05.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":22381,"price":230,"value":5147630.0,"ownership":{"direct":true},"balance_after":38137,"source":{"system":"sec-edgar","filing":"0001951400-26-000004","document":"form4-02272026_050202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000004/form4-02272026_050202.xml","form_type":"4"}},{"id":12774,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-02-27T22:00:05.000Z","date":"2026-02-25","kind":"exercise","planned":true,"acquired":true,"shares":7292,"price":192.86,"value":1406335.12,"ownership":{"direct":true},"balance_after":60518,"source":{"system":"sec-edgar","filing":"0001951400-26-000004","document":"form4-02272026_050202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000004/form4-02272026_050202.xml","form_type":"4"}},{"id":12773,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-02-27T22:00:05.000Z","date":"2026-02-25","kind":"exercise","planned":true,"acquired":true,"shares":7775,"price":175.28,"value":1362802.0,"ownership":{"direct":true},"balance_after":53226,"source":{"system":"sec-edgar","filing":"0001951400-26-000004","document":"form4-02272026_050202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000004/form4-02272026_050202.xml","form_type":"4"}},{"id":12772,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-02-27T22:00:05.000Z","date":"2026-02-25","kind":"exercise","planned":true,"acquired":true,"shares":7314,"price":149.62,"value":1094320.68,"ownership":{"direct":true},"balance_after":45451,"source":{"system":"sec-edgar","filing":"0001951400-26-000004","document":"form4-02272026_050202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000004/form4-02272026_050202.xml","form_type":"4"}},{"id":13216,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2026-02-20T23:35:21.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 6,500 on February 18, 2027, 6,500 on February 18, 2028, and 6,500 on February 18, 2029."}],"balance_after":19500,"derivative":{"exercise_price":230.04,"expiration_date":"2036-02-17","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001951400-26-000002","document":"form4-02202026_060211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000002/form4-02202026_060211.xml","form_type":"4"}},{"id":13215,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-02-20T23:35:21.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":5808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 13, 2025. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2026."}],"balance_after":38137,"source":{"system":"sec-edgar","filing":"0001951400-26-000002","document":"form4-02202026_060211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000002/form4-02202026_060211.xml","form_type":"4"}},{"id":13214,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-02-20T23:35:21.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":5628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 15, 2024. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2026."}],"balance_after":32329,"source":{"system":"sec-edgar","filing":"0001951400-26-000002","document":"form4-02202026_060211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000002/form4-02202026_060211.xml","form_type":"4"}},{"id":13213,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-02-20T23:35:21.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":5792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 16, 2023. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2026."}],"balance_after":26701,"source":{"system":"sec-edgar","filing":"0001951400-26-000002","document":"form4-02202026_060211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000002/form4-02202026_060211.xml","form_type":"4"}},{"id":13212,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-02-20T23:35:21.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":16290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 16, 2023. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2026."}],"balance_after":20909,"source":{"system":"sec-edgar","filing":"0001951400-26-000002","document":"form4-02202026_060211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000195140026000002/form4-02202026_060211.xml","form_type":"4"}},{"id":26203,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2025-03-04T22:00:18.000Z","date":"2025-03-03","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":7775,"price":175.28,"value":1362802.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":15549,"derivative":{"exercise_price":175.28,"exercise_date":"2025-02-15","expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":7775},"source":{"system":"sec-edgar","filing":"0001415889-25-006578","document":"form4-03042025_050301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006578/form4-03042025_050301.xml","form_type":"4"}},{"id":26202,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2025-03-04T22:00:18.000Z","date":"2025-03-03","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":7315,"price":149.62,"value":1094470.3,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":7314,"derivative":{"exercise_price":149.62,"exercise_date":"2024-02-16","expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":7315},"source":{"system":"sec-edgar","filing":"0001415889-25-006578","document":"form4-03042025_050301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006578/form4-03042025_050301.xml","form_type":"4"}},{"id":26201,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2025-03-04T22:00:18.000Z","date":"2025-03-03","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":2918,"price":144.54,"value":421767.72,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":144.54,"exercise_date":"2023-02-17","expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":2918},"source":{"system":"sec-edgar","filing":"0001415889-25-006578","document":"form4-03042025_050301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006578/form4-03042025_050301.xml","form_type":"4"}},{"id":26200,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-03-04T22:00:18.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":18008,"price":210,"value":3781680.0,"ownership":{"direct":true},"balance_after":4619,"source":{"system":"sec-edgar","filing":"0001415889-25-006578","document":"form4-03042025_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006578/form4-03042025_050301.xml","form_type":"4"}},{"id":26199,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-03-04T22:00:18.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":true,"shares":7775,"price":175.28,"value":1362802.0,"ownership":{"direct":true},"balance_after":22627,"source":{"system":"sec-edgar","filing":"0001415889-25-006578","document":"form4-03042025_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006578/form4-03042025_050301.xml","form_type":"4"}},{"id":26198,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-03-04T22:00:18.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":true,"shares":7315,"price":149.62,"value":1094470.3,"ownership":{"direct":true},"balance_after":14852,"source":{"system":"sec-edgar","filing":"0001415889-25-006578","document":"form4-03042025_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006578/form4-03042025_050301.xml","form_type":"4"}},{"id":26197,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-03-04T22:00:18.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":true,"shares":2918,"price":144.54,"value":421767.72,"ownership":{"direct":true},"balance_after":7537,"source":{"system":"sec-edgar","filing":"0001415889-25-006578","document":"form4-03042025_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006578/form4-03042025_050301.xml","form_type":"4"}},{"id":26196,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-03-04T22:00:18.000Z","date":"2025-02-28","kind":"sale","planned":true,"acquired":false,"shares":363,"price":207.19,"value":75209.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.12 to $207.37, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4619,"source":{"system":"sec-edgar","filing":"0001415889-25-006578","document":"form4-03042025_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006578/form4-03042025_050301.xml","form_type":"4"}},{"id":26195,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-03-04T22:00:18.000Z","date":"2025-02-28","kind":"sale","planned":true,"acquired":false,"shares":6811,"price":206.62,"value":1407288.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.01 to $207, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4982,"source":{"system":"sec-edgar","filing":"0001415889-25-006578","document":"form4-03042025_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006578/form4-03042025_050301.xml","form_type":"4"}},{"id":26194,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-03-04T22:00:18.000Z","date":"2025-02-28","kind":"sale","planned":true,"acquired":false,"shares":2718,"price":205.38,"value":558222.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.99 to $205.98, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":11793,"source":{"system":"sec-edgar","filing":"0001415889-25-006578","document":"form4-03042025_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006578/form4-03042025_050301.xml","form_type":"4"}},{"id":26193,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-03-04T22:00:18.000Z","date":"2025-02-28","kind":"tax_withholding","planned":true,"acquired":false,"shares":7870,"price":205.02,"value":1613507.4,"ownership":{"direct":true},"balance_after":14511,"source":{"system":"sec-edgar","filing":"0001415889-25-006578","document":"form4-03042025_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006578/form4-03042025_050301.xml","form_type":"4"}},{"id":26997,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-02-24T22:00:09.000Z","date":"2025-02-20","kind":"sale","planned":true,"acquired":false,"shares":3994,"price":198.12,"value":791291.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.88 to $198.65, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":22381,"source":{"system":"sec-edgar","filing":"0001415889-25-005291","document":"form4-02242025_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925005291/form4-02242025_050201.xml","form_type":"4"}},{"id":26996,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-02-24T22:00:09.000Z","date":"2025-02-20","kind":"sale","planned":true,"acquired":false,"shares":1784,"price":197.4,"value":352161.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.87 to $197.7, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":26375,"source":{"system":"sec-edgar","filing":"0001415889-25-005291","document":"form4-02242025_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925005291/form4-02242025_050201.xml","form_type":"4"}},{"id":28011,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2025-02-18T22:00:18.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":21875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 7,292 on February 13, 2026, 7,292 on February 13, 2027, and 7,291 on February 13, 2028."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 7,292 on February 13, 2026, 7,292 on February 13, 2027, and 7,291 on February 13, 2028."}],"balance_after":21875,"derivative":{"exercise_price":192.86,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":21875},"source":{"system":"sec-edgar","filing":"0001415889-25-004461","document":"form4-02182025_050214.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004461/form4-02182025_050214.xml","form_type":"4"}},{"id":28010,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-02-18T22:00:18.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":5630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 15, 2024. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2025."}],"balance_after":28159,"source":{"system":"sec-edgar","filing":"0001415889-25-004461","document":"form4-02182025_050214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004461/form4-02182025_050214.xml","form_type":"4"}},{"id":28009,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-02-18T22:00:18.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":5792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 16, 2023. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2025."}],"balance_after":22529,"source":{"system":"sec-edgar","filing":"0001415889-25-004461","document":"form4-02182025_050214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004461/form4-02182025_050214.xml","form_type":"4"}},{"id":28008,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-02-18T22:00:18.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":1844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 17, 2022. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2025."}],"balance_after":16737,"source":{"system":"sec-edgar","filing":"0001415889-25-004461","document":"form4-02182025_050214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004461/form4-02182025_050214.xml","form_type":"4"}},{"id":28007,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-02-18T22:00:18.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":4496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 17, 2022. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2025."}],"balance_after":14893,"source":{"system":"sec-edgar","filing":"0001415889-25-004461","document":"form4-02182025_050214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004461/form4-02182025_050214.xml","form_type":"4"}},{"id":44463,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-03-01T22:50:38.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":3387,"price":178.04,"value":603021.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.51 to $177.88, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10397,"source":{"system":"sec-edgar","filing":"0001415889-24-006162","document":"form4-03012024_050317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924006162/form4-03012024_050317.xml","form_type":"4"}},{"id":44462,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-03-01T22:50:38.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":6504,"price":177.05,"value":1151533.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.51 to $177.43, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 1, 2023."}],"balance_after":13784,"source":{"system":"sec-edgar","filing":"0001415889-24-006162","document":"form4-03012024_050317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924006162/form4-03012024_050317.xml","form_type":"4"}},{"id":44461,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-03-01T22:50:38.000Z","date":"2024-02-28","kind":"tax_withholding","planned":true,"acquired":false,"shares":7885,"price":178.99,"value":1411336.15,"ownership":{"direct":true},"balance_after":20288,"source":{"system":"sec-edgar","filing":"0001415889-24-006162","document":"form4-03012024_050317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924006162/form4-03012024_050317.xml","form_type":"4"}},{"id":44696,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2024-02-27T22:10:08.000Z","date":"2024-02-23","kind":"exercise","planned":true,"acquired":true,"shares":7315,"price":149.62,"value":1094470.3,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":14629,"derivative":{"exercise_price":149.62,"exercise_date":"2024-02-16","expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":7315},"source":{"system":"sec-edgar","filing":"0001415889-24-005544","document":"form4-02272024_050202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924005544/form4-02272024_050202.xml","form_type":"4"}},{"id":44695,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2024-02-27T22:10:08.000Z","date":"2024-02-23","kind":"exercise","planned":true,"acquired":true,"shares":3519,"price":105.92,"value":372732.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":105.92,"exercise_date":"2022-02-18","expiration_date":"2031-02-17","underlying":"Common Stock","underlying_shares":3519},"source":{"system":"sec-edgar","filing":"0001415889-24-005544","document":"form4-02272024_050202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924005544/form4-02272024_050202.xml","form_type":"4"}},{"id":44694,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2024-02-27T22:10:08.000Z","date":"2024-02-23","kind":"exercise","planned":true,"acquired":true,"shares":2919,"price":144.54,"value":421912.26,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":2919,"derivative":{"exercise_price":144.54,"exercise_date":"2023-02-17","expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":2919},"source":{"system":"sec-edgar","filing":"0001415889-24-005544","document":"form4-02272024_050202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924005544/form4-02272024_050202.xml","form_type":"4"}},{"id":44693,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-27T22:10:08.000Z","date":"2024-02-23","kind":"sale","planned":true,"acquired":false,"shares":13753,"price":177.51,"value":2441295.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.01 to $177.73, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":28173,"source":{"system":"sec-edgar","filing":"0001415889-24-005544","document":"form4-02272024_050202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924005544/form4-02272024_050202.xml","form_type":"4"}},{"id":44692,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-27T22:10:08.000Z","date":"2024-02-23","kind":"exercise","planned":true,"acquired":true,"shares":7315,"price":149.62,"value":1094470.3,"ownership":{"direct":true},"balance_after":41926,"source":{"system":"sec-edgar","filing":"0001415889-24-005544","document":"form4-02272024_050202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924005544/form4-02272024_050202.xml","form_type":"4"}},{"id":44691,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-27T22:10:08.000Z","date":"2024-02-23","kind":"exercise","planned":true,"acquired":true,"shares":3519,"price":105.92,"value":372732.48,"ownership":{"direct":true},"balance_after":34611,"source":{"system":"sec-edgar","filing":"0001415889-24-005544","document":"form4-02272024_050202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924005544/form4-02272024_050202.xml","form_type":"4"}},{"id":44690,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-27T22:10:08.000Z","date":"2024-02-23","kind":"exercise","planned":true,"acquired":true,"shares":2919,"price":144.54,"value":421912.26,"ownership":{"direct":true},"balance_after":31092,"source":{"system":"sec-edgar","filing":"0001415889-24-005544","document":"form4-02272024_050202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924005544/form4-02272024_050202.xml","form_type":"4"}},{"id":45432,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2024-02-20T22:15:53.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":23324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 7,775 on February 15, 2025, 7,775 on February 15, 2026, and 7,774 on February 15, 2027."}],"balance_after":23324,"derivative":{"exercise_price":0,"exercise_date":"2025-02-15","expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":23324},"source":{"system":"sec-edgar","filing":"0001415889-24-004420","document":"form4-02202024_050232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004420/form4-02202024_050232.xml","form_type":"4"}},{"id":45431,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-20T22:15:53.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":5792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 16, 2023. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":28173,"source":{"system":"sec-edgar","filing":"0001415889-24-004420","document":"form4-02202024_050232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004420/form4-02202024_050232.xml","form_type":"4"}},{"id":45430,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-20T22:15:53.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":1844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 17, 2022. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":22381,"source":{"system":"sec-edgar","filing":"0001415889-24-004420","document":"form4-02202024_050232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004420/form4-02202024_050232.xml","form_type":"4"}},{"id":45429,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-20T22:15:53.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":2138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on a relative return on invested capital measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":20537,"source":{"system":"sec-edgar","filing":"0001415889-24-004420","document":"form4-02202024_050232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004420/form4-02202024_050232.xml","form_type":"4"}},{"id":45428,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-20T22:15:53.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":8022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on earnings per share and relative return on invested capital. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":18399,"source":{"system":"sec-edgar","filing":"0001415889-24-004420","document":"form4-02202024_050232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004420/form4-02202024_050232.xml","form_type":"4"}},{"id":47295,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2024-02-06T22:00:10.000Z","date":"2024-02-02","kind":"exercise","planned":true,"acquired":false,"shares":2919,"price":144.54,"value":421912.26,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":5837,"derivative":{"exercise_price":144.54,"exercise_date":"2023-02-17","expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":2919},"source":{"system":"sec-edgar","filing":"0001415889-24-002828","document":"form4-02062024_050202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924002828/form4-02062024_050202.xml","form_type":"4"}},{"id":47294,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-06T22:00:10.000Z","date":"2024-02-02","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":2919,"price":170,"value":496230.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on February 14, 2023."}],"balance_after":10377,"source":{"system":"sec-edgar","filing":"0001415889-24-002828","document":"form4-02062024_050202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924002828/form4-02062024_050202.xml","form_type":"4"}},{"id":47293,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-06T22:00:10.000Z","date":"2024-02-02","kind":"grant","planned":true,"acquired":true,"shares":2919,"price":144.54,"value":421912.26,"ownership":{"direct":true},"balance_after":13296,"source":{"system":"sec-edgar","filing":"0001415889-24-002828","document":"form4-02062024_050202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924002828/form4-02062024_050202.xml","form_type":"4"}},{"id":56797,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2023-04-05T21:00:12.000Z","date":"2023-04-03","kind":"exercise","planned":false,"acquired":false,"shares":3520,"price":105.92,"value":372838.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":3520,"derivative":{"exercise_price":105.92,"exercise_date":"2022-02-18","expiration_date":"2031-02-17","underlying":"Common Stock","underlying_shares":3520},"source":{"system":"sec-edgar","filing":"0001415889-23-006300","document":"form4-04052023_050401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923006300/form4-04052023_050401.xml","form_type":"4"}},{"id":56796,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-04-05T21:00:12.000Z","date":"2023-04-03","kind":"sale","planned":false,"acquired":false,"shares":3520,"price":160,"value":563200.0,"ownership":{"direct":true},"balance_after":10377,"source":{"system":"sec-edgar","filing":"0001415889-23-006300","document":"form4-04052023_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923006300/form4-04052023_050401.xml","form_type":"4"}},{"id":56795,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-04-05T21:00:12.000Z","date":"2023-04-03","kind":"exercise","planned":false,"acquired":true,"shares":3520,"price":105.92,"value":372838.4,"ownership":{"direct":true},"balance_after":13897,"source":{"system":"sec-edgar","filing":"0001415889-23-006300","document":"form4-04052023_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923006300/form4-04052023_050401.xml","form_type":"4"}},{"id":57870,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-03-02T22:06:13.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":805,"price":153.38,"value":123470.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.36 to $153.43, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10377,"source":{"system":"sec-edgar","filing":"0001415889-23-003855","document":"form4-03022023_100358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923003855/form4-03022023_100358.xml","form_type":"4"}},{"id":57869,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-03-02T22:06:13.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":11330,"price":153.06,"value":1734169.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.37 to $153.36, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":11182,"source":{"system":"sec-edgar","filing":"0001415889-23-003855","document":"form4-03022023_100358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923003855/form4-03022023_100358.xml","form_type":"4"}},{"id":57868,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-03-02T22:06:13.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":9656,"price":154.28,"value":1489727.68,"ownership":{"direct":true},"balance_after":22512,"source":{"system":"sec-edgar","filing":"0001415889-23-003855","document":"form4-03022023_100358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923003855/form4-03022023_100358.xml","form_type":"4"}},{"id":58397,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2023-02-22T22:00:38.000Z","date":"2023-02-21","kind":"exercise","acquired":false,"shares":7364,"price":93.5,"value":688534.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":93.5,"exercise_date":"2024-02-16","expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":7364},"source":{"system":"sec-edgar","filing":"0001415889-23-003007","document":"form4-02222023_050201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923003007/form4-02222023_050201.xml","form_type":"4"}},{"id":58396,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-22T22:00:38.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":3933,"price":151.29,"value":595023.57,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.12 to $151.49, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":32168,"source":{"system":"sec-edgar","filing":"0001415889-23-003007","document":"form4-02222023_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923003007/form4-02222023_050201.xml","form_type":"4"}},{"id":58395,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-22T22:00:38.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":3431,"price":150.73,"value":517154.63,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.12 to $151.11, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":36101,"source":{"system":"sec-edgar","filing":"0001415889-23-003007","document":"form4-02222023_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923003007/form4-02222023_050201.xml","form_type":"4"}},{"id":58394,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-22T22:00:38.000Z","date":"2023-02-21","kind":"exercise","acquired":true,"shares":7364,"price":93.5,"value":688534.0,"ownership":{"direct":true},"balance_after":39532,"source":{"system":"sec-edgar","filing":"0001415889-23-003007","document":"form4-02222023_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923003007/form4-02222023_050201.xml","form_type":"4"}},{"id":58467,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (Right to buy)","published_at":"2023-02-21T23:11:02.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":21944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 7,315 on February 16, 2024, 7,315 on February 16, 2025, and 7,314 on February 16, 2026."}],"balance_after":21944,"derivative":{"exercise_price":149.62,"exercise_date":"2024-02-16","expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":21944},"source":{"system":"sec-edgar","filing":"0001415889-23-002943","document":"form4-02212023_110239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002943/form4-02212023_110239.xml","form_type":"4"}},{"id":58466,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-21T23:11:02.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":1846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 17, 2022. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":32168,"source":{"system":"sec-edgar","filing":"0001415889-23-002943","document":"form4-02212023_110239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002943/form4-02212023_110239.xml","form_type":"4"}},{"id":58465,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-21T23:11:02.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":2140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":30322,"source":{"system":"sec-edgar","filing":"0001415889-23-002943","document":"form4-02212023_110239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002943/form4-02212023_110239.xml","form_type":"4"}},{"id":58464,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-21T23:11:02.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":3368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":28182,"source":{"system":"sec-edgar","filing":"0001415889-23-002943","document":"form4-02212023_110239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002943/form4-02212023_110239.xml","form_type":"4"}},{"id":58463,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11031,"kind":"person","name":"Siatis Perry C","position":1,"cik":"0001951400","reported_name":"Siatis Perry C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-21T23:11:02.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":14437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":24814,"source":{"system":"sec-edgar","filing":"0001415889-23-002943","document":"form4-02212023_110239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002943/form4-02212023_110239.xml","form_type":"4"}}]}